Combination of Diabetes Drug with Secretome Improves Glycemic Control in Type 2 DM Patients
by dr. Esther Kristiningrum
| 13 July 2026
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disease characterized primarily by persistent hyperglycemia due to impaired insulin secretion, insulin resistance, or both. The global prevalence of T2DM continues to rise sharply, posing a significant public health challenge.